Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in queensland australia

Cancer

Volumn 115, Issue 6, 2009, Pages 1318-1327

  Geller, Alan C ^a   Elwood, Mark ^b   Swetter, Susan M ^c,d   Brooks, Daniel R ^e   Aitken, Joanne ^f,g   Youl, Philippa H ^f   Demierre, Marie France ^h   Baade, Peter D ^f,i  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Early detection; Melanoma; Nodular melanoma; Physician; Screening

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER DIAGNOSIS; CANCER INVASION; CANCER REGISTRY; CANCER SCREENING; EARLY DIAGNOSIS; FEMALE; HEALTH EDUCATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; TEST RETEST RELIABILITY; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; EARLY DETECTION OF CANCER; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MELANOMA; MIDDLE AGED; PHYSICAL EXAMINATION; QUEENSLAND; QUESTIONNAIRES; REGISTRIES; SKIN NEOPLASMS;

EID: 63449084315     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24162     Document Type: Article

References (33)

1. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-3648.
2. Crocetti E, Carli P. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness. Eur J Dermatol. 2003;13:72-75.
3. Ries LAG, Melbert D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975-2005/, based on November 2007 SEER data submission, posted to the SEER web site, 2008, accessed January 22, 2009.
4. Geller AC, Swetter SM, Brooks K, Demierre MF. Yaroch AL. Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J Am Acad Dermatol. 2007;57:555-572.
5. Abbasi NR, Shaw HM, Rigel DS, et al. Early diagnosis of cutaneous melanoma; revisiting the ABCD criteria. JAMA. 2004;292:2771-2776.
6. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93:678-683.
7. Balzi D, Carli P, Giannotti B, Paci E, Buiatti E. Cutaneous melanoma in the Florentine area, Italy: incidence, survival and mortality between 1985 and 1994. Eur J Cancer Prev. 2003;12:43-48.
8. Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer. 2001;92:457-462.
9. Kelly JW. Nodular melanoma: how current approaches to early detection are failing. JDrugs Dermatol. 2005;4:790-793.
10. Demierre MF, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol. 2005;141:745-750.
11. Chamberlain AJ, Fritschi L, Giles GG, et al. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol. 2002;138: 609-614.
12. Bergenmar M, Hansson J, Brandberg Y. Detection of nodular and superficial spreading melanoma with tumor thickness ≤2.00 mm-an interview study. Eur J Cancer Prev. 2002;11:49-55.
13. Carli P, De Giorgi V, Palli D, et al. Patterns of detection of superficial spreading and nodular-type melanoma: a multi-center Italian study. Dermatol Surg. 2004;30:1371- 1375; discussion 1375-1376.
14. McPherson M, Elwood M, English DR, et al. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol. 2006;54:783-792.
15. Baade PD, English DR, Youl PH, McPherson M, Elwood MJ, Aitken JF. The relationship between melanoma thickness and time to diagnosis in a large population-based study. Arch Dermatol. 2006;142:1422-1427.
16. Aitken JF, Youl PH, Janda M, et al. Validity of self- reported skin screening histories. Am J Epidemiol. 2004; 159:1098-1105.
17. Krige JE, Isaacs S, Hudson DA, King HS, Strover RM, Johnson CA. Delay in the diagnosis of cutaneous melanoma: a prospective study in 250 patients. Cancer. 1991;68:2064-2068.
18. Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE. Is physician detection associated with thinner melanomas? JAMA. 1999;281:640-643.
19. Richard MA, Grob JJ, Avril MF, et al. Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol. 1999;135:269-274.
20. Brady MS, Oliveria SA, Christos PJ, et al. Patterns of detection in patients with cutaneous melanoma: implications for secondary prevention. Cancer. 2000;89:342-347.
21. Richard MA, Grob JJ, Avril MR, et al. Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer. 2000;89:280-285.
22. Schwartz JL, Wang TS, Hamilton TA, Lowe L, Sondak VK, Johnson TM. Thin primary cutaneous melanoma: associated detection patterns, lesion characteristics, and patient characteristics. Cancer. 2002;95:1562-1568.
23. Fisher NM, Schaffer JV, Berwick M, Bolognia JL. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. JAm Acad Dermatol. 2005;53:393-406.
24. Carli P, DeGiorgi VD, Palli D, et al. Dermatologist detection and skin self-examination are associated with thinner melanomas. Arch Dermatol. 2003;139:607-612.
25. Institute of Medicine. Extending Medicare Coverage for Prevention and Other Services. Washington, DC: National Academy Press; 2000.
26. Liu W, Dowling JP, Murray WK, et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol. 2006;142:1551-1558; discussion 1638-1640.
27. Grob JJ, Richard MA, Gouvernet J, et al. The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: a prospective study. Int J Cancer. 2002;102:34-38.
28. Elder D, Viros A, Fridlyand J, et al. Histomorphological signature of mutation status in melanoma. In: American Association for Cancer Research Annual Meeting: Proceedings, Los Angeles, California, April 14-18, 2007. Philadelphia, PA: American Association for Cancer Research; 2007. Abstract 154.
29. Miracco C, Santopietro R, Biagioli M, et al. Different patterns of cell proliferation and death and oncogene expression in cutaneous malignant melanoma. J Cutan Pathol. 1998;25:244-251.
30. Bastian BC, Kashani-Sabet M, Hamm H, et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res. 2000;60:1968-1973.
31. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353: 2135-2147; discussion 2104-2107.
32. Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003;95:1878-1890.
33. World Health Organization. International Classification of Diseases for Oncology. Geneva, Switzerland: World Health Organization; 1976.